aim study investigate association overexpression cyclin d1 response therapy immunohistochemical overexpression cyclin d1 determined specimens diagnostic biopsies NUMBER primary cases squamous cell carcinoma head neck scchn using polyclonal antiserum tumor response rates estimated curative treatment surgery radiotherapy chemotherapy patients tumors overexpressing cyclin d1 showed complete partial response neoadjuvant chemotherapy addition majority cyclin d1 negative tumors did respond treatment p NUMBER fishers exact test study indicates immunohistochemical assessment cyclin d1 expression scchn new predictive marker select subgroup patients benefit neoadjuvant chemotherapy paraffin embedded fu cisplatin NUMBER